Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Pramipexole in Parkinson's Disease
NCT00274131Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 1998
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of pramipexole in Parkinson's disease (PD), sponsored by Boehringer Ingelheim. Started Dec 1998; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00274131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274131.